Tweet
China-made Ebola vaccine permitted for overseas trial
Last Updated: Tuesday, October 13, 2015 - 16:26 Beijing: A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
The Chinese Ebola vaccine has three major features. First, the vaccine is the first based on the Ebola virus strain responsible for the West African outbreak in 2014, People's Daily reported on Tuesday.
Until now, all tested Ebola vaccines were based on a strain from the Democratic Republic of the Congo outbreak of 1976.
Read more: http://zeenews.india.com/news/health...l_1809611.html
Last Updated: Tuesday, October 13, 2015 - 16:26 Beijing: A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
The Chinese Ebola vaccine has three major features. First, the vaccine is the first based on the Ebola virus strain responsible for the West African outbreak in 2014, People's Daily reported on Tuesday.
Until now, all tested Ebola vaccines were based on a strain from the Democratic Republic of the Congo outbreak of 1976.
Read more: http://zeenews.india.com/news/health...l_1809611.html